LIFILJA Trademark

Trademark Overview

On Monday, December 3, 2018, a trademark application was filed for LIFILJA with the United States Patent and Trademark Office. The USPTO has given the LIFILJA trademark a serial number of 88214225. The federal status of this trademark filing is REGISTERED as of Tuesday, December 27, 2022. This trademark is owned by Gilead Sciences Ireland UC. The LIFILJA trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis
lifilja

General Information

Serial Number88214225
Word MarkLIFILJA
Filing DateMonday, December 3, 2018
Status700 - REGISTERED
Status DateTuesday, December 27, 2022
Registration Number6932892
Registration DateTuesday, December 27, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2019

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Tuesday, December 27, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 27, 2022REGISTERED-PRINCIPAL REGISTER
Monday, November 21, 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, September 12, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, November 17, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, November 17, 2022PETITION GRANTED - REQUEST TO DELETE 1(B) FILED
Monday, November 14, 2022ASSIGNED TO PETITION STAFF
Wednesday, October 19, 2022TEAS PETITION TO REVIVE AND REQUEST TO DELETE 1B OR G/S
Monday, October 17, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 17, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 2, 2022SOU EXTENSION 5 GRANTED
Wednesday, January 26, 2022SOU EXTENSION 5 FILED
Wednesday, February 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 26, 2022TEAS EXTENSION RECEIVED
Thursday, July 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 13, 2021SOU EXTENSION 4 GRANTED
Tuesday, July 13, 2021SOU EXTENSION 4 FILED
Tuesday, July 13, 2021TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 8, 2021SOU EXTENSION 3 GRANTED
Friday, January 8, 2021SOU EXTENSION 3 FILED
Friday, January 8, 2021TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 17, 2020SOU EXTENSION 2 GRANTED
Friday, July 17, 2020SOU EXTENSION 2 FILED
Friday, July 17, 2020TEAS EXTENSION RECEIVED
Friday, January 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 29, 2020SOU EXTENSION 1 GRANTED
Wednesday, January 29, 2020SOU EXTENSION 1 FILED
Wednesday, January 29, 2020TEAS EXTENSION RECEIVED
Tuesday, September 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 23, 2019ASSIGNED TO LIE
Friday, May 17, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, February 14, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 14, 2019LETTER OF SUSPENSION E-MAILED
Thursday, February 14, 2019SUSPENSION LETTER WRITTEN
Wednesday, February 13, 2019ASSIGNED TO EXAMINER
Wednesday, December 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 6, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

lifilja preparations pharmaceutical treatment disorders diseases anti respiratory autoimmune pulmonary kidney